Maryam Roudbary

1.9k total citations
62 papers, 1.2k citations indexed

About

Maryam Roudbary is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Maryam Roudbary has authored 62 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 25 papers in Epidemiology and 9 papers in Molecular Biology. Recurrent topics in Maryam Roudbary's work include Antifungal resistance and susceptibility (40 papers), Fungal Infections and Studies (21 papers) and Nail Diseases and Treatments (7 papers). Maryam Roudbary is often cited by papers focused on Antifungal resistance and susceptibility (40 papers), Fungal Infections and Studies (21 papers) and Nail Diseases and Treatments (7 papers). Maryam Roudbary collaborates with scholars based in Iran, Portugal and Brazil. Maryam Roudbary's co-authors include Raheleh Roudi, Nicholas Syn, Célia F. Rodrigues, Lucia Černáková, Shirin Farahyar, Fatemeh Nikoomanesh, André Luis Souza dos Santos, Mehraban Falahati, Sunil Kumar and Marta H. Branquinha and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Maryam Roudbary

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Roudbary Iran 20 582 393 330 219 180 62 1.2k
Nuria Trevijano‐Contador Spain 14 609 1.0× 566 1.4× 291 0.9× 105 0.5× 330 1.8× 21 1.3k
Taissa Vila United States 22 831 1.4× 498 1.3× 382 1.2× 165 0.8× 167 0.9× 38 1.6k
Megha Gulati United States 15 896 1.5× 458 1.2× 571 1.7× 202 0.9× 125 0.7× 20 1.5k
Ana Carolina Alves de Paula e Silva Brazil 15 454 0.8× 425 1.1× 188 0.6× 79 0.4× 172 1.0× 20 878
Kelly Ishida Brazil 25 649 1.1× 585 1.5× 328 1.0× 133 0.6× 374 2.1× 79 1.8k
Renátó Kovács Hungary 20 698 1.2× 421 1.1× 314 1.0× 145 0.7× 174 1.0× 79 1.2k
Maria Elisa Rodrigues Portugal 21 544 0.9× 289 0.7× 641 1.9× 131 0.6× 127 0.7× 50 1.5k
Caroline Barcelos Costa-Orlandi Brazil 15 375 0.6× 414 1.1× 198 0.6× 81 0.4× 150 0.8× 24 933
Rocio Garcia‐Rubio Spain 15 753 1.3× 518 1.3× 296 0.9× 78 0.4× 355 2.0× 19 1.3k
Mafalda Cavalheiro Portugal 14 618 1.1× 365 0.9× 464 1.4× 98 0.4× 133 0.7× 17 1.1k

Countries citing papers authored by Maryam Roudbary

Since Specialization
Citations

This map shows the geographic impact of Maryam Roudbary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Roudbary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Roudbary more than expected).

Fields of papers citing papers by Maryam Roudbary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Roudbary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Roudbary. The network helps show where Maryam Roudbary may publish in the future.

Co-authorship network of co-authors of Maryam Roudbary

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Roudbary. A scholar is included among the top collaborators of Maryam Roudbary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Roudbary. Maryam Roudbary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramos, Lívia S., Antônio L. Braga, Leonardo L. Giovanini, et al.. (2025). The multidrug-resistant Candida auris, Candida haemulonii complex and phylogenetic related species: Insights into antifungal resistance mechanisms. Current Research in Microbial Sciences. 8. 100354–100354. 6 indexed citations
2.
Nikoomanesh, Fatemeh, et al.. (2024). Evaluation of antifungal activity of natural compounds on growth and aflatoxin B1 production of Aspergillus parasiticus and Aspergillus flavus. Molecular Biology Reports. 51(1). 53–53. 8 indexed citations
3.
4.
Tajbakhsh, Mahmood, et al.. (2023). Design, synthesis, biological evaluation, and molecular docking of euparin and 2‑hydroxy acetophenone hydrazone derivatives as potential AchE inhibitors. Journal of Molecular Structure. 1293. 136284–136284. 4 indexed citations
5.
Beardsley, Justin, et al.. (2023). Thymoquinone Antifungal Activity against Candida glabrata Oral Isolates from Patients in Intensive Care Units—An In Vitro Study. Metabolites. 13(4). 580–580. 8 indexed citations
6.
Nikoomanesh, Fatemeh, et al.. (2023). Combination of Farnesol with Common Antifungal Drugs: Inhibitory Effect against Candida Species Isolated from Women with RVVC. Medicina. 59(4). 743–743. 12 indexed citations
7.
Amini, Seyed Mohammad, Muhammad Ibrahim Getso, Shirin Farahyar, et al.. (2023). Antifungal activity of green-synthesized curcumin-coated silver nanoparticles alone and in combination with fluconazole and itraconazole against Candida and Aspergillus species.. SHILAP Revista de lepidopterología. 9(3). 38–44. 5 indexed citations
8.
Kumar, Sunil, Awanish Kumar, Maryam Roudbary, et al.. (2022). Overview on the Infections Related to Rare Candida Species. Pathogens. 11(9). 963–963. 55 indexed citations
9.
Roudbary, Maryam, Sunil Kumar, Awanish Kumar, et al.. (2021). Overview on the Prevalence of Fungal Infections, Immune Response, and Microbiome Role in COVID-19 Patients. Journal of Fungi. 7(9). 720–720. 50 indexed citations
10.
Silva, Laura Nunes, Thaís P. Mello, Lívia S. Ramos, et al.. (2020). Fungal Infections in COVID-19-Positive Patients: A Lack of Optimal Treatment Options. Current Topics in Medicinal Chemistry. 20(22). 1951–1957. 29 indexed citations
11.
Nikoomanesh, Fatemeh, et al.. (2019). Design and synthesis of mucoadhesive nanogel containing farnesol: investigation of the effect on HWP1, SAP6 and Rim101 genes expression of Candida albicans in vitro. Artificial Cells Nanomedicine and Biotechnology. 47(1). 64–72. 30 indexed citations
12.
Kouhsari, Ebrahim, et al.. (2018). Antibacterial, antifungal and cytotoxic activities of some medicinal plants against multidrug resistance pathogens. Reviews in Medical Microbiology. 29(4). 182–188. 6 indexed citations
13.
Roudbary, Maryam, et al.. (2017). Preparation and characterization of ZnO nanoparticles coated by chitosan-linoleic acid; fungal growth and biofilm assay. Bratislavské lekárske listy/Bratislava medical journal. 118(3). 169–174. 16 indexed citations
14.
Alizadeh, Ali Mohammad, Maryam Roudbary, Mahmood Khaniki, et al.. (2016). Effect of Long- and Short- term of Fumonisin B1 Orally Administration on Esophagus Tissue in Animal Model. SHILAP Revista de lepidopterología. 1 indexed citations
15.
16.
Pagheh, Abdol Sattar, et al.. (2015). Molecular Identification and Epidemiological Aspects of Dermatophytosis in Tehran, Iran. SHILAP Revista de lepidopterología. 9 indexed citations
17.
Ahmadabad, Hasan Namdar, et al.. (2013). Anti-fungal Effect of Fresh, Aged and Pickled Garlic Aqueous Extract on Candida Albicans;in vitro. The Horizon of Medical Sciences. 18(4). 179–183.
18.
Roudbary, Maryam, et al.. (2013). Identification of Candida species isolated from Iranian women with vaginal candidiasis by PCR-RFLP method. European Journal of Experimental Biology. 3(6). 10 indexed citations
19.
Roudbary, Maryam, et al.. (2012). Relation of ALS 1 and ALS3 genes and fluconazole resistance in Candida albicans isolated from vaginal candidacies. 2(2). 170–174. 7 indexed citations
20.
Roudbary, Maryam, et al.. (2009). The Effects of Candida Albicans Cell Wall Protein Fraction on Dendritic Cell Maturation. PubMed. 6(2). 67–74. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuria Trevijano‐Contador Breakdown of academic impact, for papers by Taissa Vila Breakdown of academic impact, for papers by Megha Gulati Breakdown of academic impact, for papers by Ana Carolina Alves de Paula e Silva Breakdown of academic impact, for papers by Kelly Ishida Breakdown of academic impact, for papers by Renátó Kovács Breakdown of academic impact, for papers by Maria Elisa Rodrigues Breakdown of academic impact, for papers by Caroline Barcelos Costa-Orlandi Breakdown of academic impact, for papers by Rocio Garcia‐Rubio Breakdown of academic impact, for papers by Mafalda Cavalheiro
Rankless by CCL
2026